ロード中...

Current Progress in CAR-T Cell Therapy for Hematological Malignancies

Immunotherapies, such as monoclonal antibody therapy and checkpoint inhibitor therapy, have shown inspiring clinical effects for the treatment of cancer. Chimeric antigen receptor T (CAR-T) cells therapy was an efficacious therapeutic approach treating hematological malignancies and encouraging resu...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Han, Donglei, Xu, Zenghui, Zhuang, Yuan, Ye, Zhenlong, Qian, Qijun
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738987/
https://ncbi.nlm.nih.gov/pubmed/33391429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.48976
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!